Barclays’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-76,700
| Closed | -$6.97M | – | 5515 |
|
|
2025
Q2 | $6.97M | Buy |
+76,700
| New | +$7M | ﹤0.01% | 1836 |
|
|
2024
Q1 | – | Sell |
-26,500
| Closed | -$2.11M | – | 5116 |
|
|
2023
Q4 | $2.11M | Sell |
26,500
-26,500
| -50% | -$1.99M | ﹤0.01% | 2880 |
|
|
2023
Q3 | $3.77M | Buy |
+53,000
| New | +$3.96M | ﹤0.01% | 1506 |
|
|
2021
Q1 | – | Sell |
-230,100
| Closed | -$19.7M | – | 4744 |
|
|
2020
Q4 | $19.7M | Hold |
230,100
| – | – | 0.01% | 843 |
|
|
2020
Q3 | $17.8M | Sell |
230,100
-1,400
| -0.6% | -$107K | 0.01% | 790 |
|
|
2020
Q2 | $17M | Sell |
231,500
-56,100
| -20% | -$3.99M | 0.01% | 714 |
|
|
2020
Q1 | $19.1M | Sell |
287,600
-122,200
| -30% | -$8.62M | 0.02% | 660 |
|
|
2019
Q4 | $28.2M | Buy |
409,800
+109,300
| +36% | +$7.45M | 0.02% | 767 |
|
|
2019
Q3 | $22.1M | Buy |
300,500
+69,400
| +30% | +$5.03M | 0.01% | 821 |
|
|
2019
Q2 | $16.6M | Sell |
231,100
-252,500
| -52% | -$17.9M | 0.01% | 1037 |
|
|
2019
Q1 | $33.1M | Sell |
483,600
-23,400
| -5% | -$1.51M | 0.02% | 599 |
|
|
2018
Q4 | $30.2M | Buy |
507,000
+283,500
| +127% | +$17.7M | 0.02% | 559 |
|
|
2018
Q3 | $15M | Buy |
223,500
+42,100
| +23% | +$2.8M | 0.01% | 1013 |
|
|
2018
Q2 | $11.8M | Sell |
181,400
-45,600
| -20% | -$2.98M | 0.01% | 1111 |
|
|
2018
Q1 | $16.3M | Sell |
227,000
-27,700
| -11% | -$1.99M | 0.01% | 948 |
|
|
2017
Q4 | $19.2M | Buy |
254,700
+14,400
| +6% | +$1.05M | 0.02% | 822 |
|
|
2017
Q3 | $17.5M | Sell |
240,300
-52,900
| -18% | -$3.81M | 0.02% | 723 |
|
|
2017
Q2 | $21.7M | Buy |
293,200
+104,400
| +55% | +$7.75M | 0.02% | 568 |
|
|
2017
Q1 | $13.8M | Sell |
188,800
-52,600
| -22% | -$3.68M | 0.02% | 699 |
|
|
2016
Q4 | $15.8M | Sell |
241,400
-6,100
| -2% | -$418K | 0.02% | 710 |
|
|
2016
Q3 | $18.3M | Buy |
247,500
+33,700
| +16% | +$2.49M | 0.02% | 585 |
|
|
2016
Q2 | $15.7M | Buy |
213,800
+114,200
| +115% | +$8.13M | 0.02% | 623 |
|
|
2016
Q1 | $6.97M | Buy |
99,600
+46,900
| +89% | +$3.12M | 0.01% | 958 |
|
|
2015
Q4 | $3.48M | Sell |
52,700
-18,500
| -26% | -$1.23M | ﹤0.01% | 1570 |
|
|
2015
Q3 | $4.49M | Sell |
71,200
-1,300
| -2% | -$84.9K | 0.01% | 1442 |
|
|
2015
Q2 | $4.71M | Buy |
72,500
+5,300
| +8% | +$360K | 0.01% | 1531 |
|
|
2015
Q1 | $4.64M | Sell |
67,200
-10,500
| -14% | -$726K | 0.01% | 1621 |
|
|
2014
Q4 | $5.36M | Sell |
77,700
-4,500
| -5% | -$304K | 0.01% | 1647 |
|
|
2014
Q3 | $5.34M | Buy |
82,200
+49,500
| +151% | +$3.26M | 0.01% | 1722 |
|
|
2014
Q2 | $2.22M | Sell |
32,700
-13,100
| -29% | -$878K | ﹤0.01% | 2479 |
|
|
2014
Q1 | $2.93M | Sell |
45,800
-248,500
| -84% | -$15.7M | ﹤0.01% | 2187 |
|
|
2013
Q4 | $19.1M | Sell |
294,300
-221,500
| -43% | -$14.2M | 0.02% | 789 |
|
|
2013
Q3 | $30.4M | Sell |
515,800
-7,800
| -1% | -$462K | 0.04% | 475 |
|
|
2013
Q2 | $30M | Buy |
+523,600
| New | +$31.1M | 0.04% | 439 |
|
Other funds holding CL
VCM
DAM
VPM
Barclays's CL Position: Q1 2026 in Review
Barclays reduced its Colgate-Palmolive (CL) stake by 22% in Q1 2026, selling an estimated $51.9M and leaving 2,113,254 shares worth $180M. The position accounts for 0.04% of the portfolio, ranked #322.
Barclays first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $794M in Q3 2024. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Barclays held 2,113,254 shares of Colgate-Palmolive worth $180M as of Q1 2026.
- Barclays sold 581,983 Colgate-Palmolive shares in Q1 2026, an estimated $51.9M.
- Colgate-Palmolive made up 0.04% of Barclays's portfolio in Q1 2026, its #322 holding.
- Barclays first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
- Barclays's Colgate-Palmolive position peaked at $794M in Q3 2024.
- 1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.